Hospitals & Healthcare News

This section covers the managerial aspects in the Healthcare industry.

Boehringer Ingelheim and BioMed X collaborate to discover new epigenetic regulators of COPD

Tuesday, January 06, 2015

BioMed X announced that they have entered into a collaboration agreement with Boehringer Ingelheim to establish a research group focusing on the identification of novel therapeutic concepts for treating patients with chronic obstructive pulmonary disease COPD Outstanding early career scientists fro..

MEDNAX announces acquisition of Anesthesiology Practice in Tennessee

Monday, January 05, 2015

MEDNAX Inc today announced the acquisition effective December 31 2014 of Metropolitan Anesthesia Alliance PLLC a private physician group practice based in Memphis Tenn The practice will become part of MEDNAXs American Anesthesiology division and represents the Company39s fourth anesthesiology practi..

SI-BONE, Inc. announces Medicare Noridian Reimbursing for MIS SI Joint Fusion

Monday, January 05, 2015

SIBONE Inc a medical device company that pioneered the use of the iFuse Implant System a minimally invasive surgical MIS device indicated for fusion for certain disorders of the sacroiliac SI joint announced that the Medicare Administrative Contractor MAC Noridian Healthcare Solutions LLC began cove..

HealthSouth completes acquisition of Encompass Home Health and Hospice

Saturday, January 03, 2015

HealthSouth Corporation the nation39s largest owner and operator of inpatient rehabilitation hospitals today announced it has completed its previously announced acquisition of privately held EHHI Holdings Inc which owns Encompass Home Health and Hospice Encompass Founded in 1998 and based in Dallas..

Lilly finalizes Novartis Animal Health acquisition for $5.4 billion

Friday, January 02, 2015

Eli Lilly and Company today announced that it has completed the acquisition of Novartis Animal Health which will further position Lilly39s Elanco as a global leader in the animal health industry The transaction first announced on April 22 has received clearance under the HartScottRodino Antitrust Im..

United Therapeutics announces signing of agreement for New Remodulin Delivery System

Friday, January 02, 2015

United Therapeutics Corporation announced today the signing of an agreement with DEKA Research Development Corp for the development of a potential technology breakthrough in the subcutaneous delivery of Remodulin treprostinil Injection to patients with pulmonary arterial hypertension PAH via a pref..